Our Projects & Collaborations

Our Past Projects

• MEDICAL Device Study
• Infectious diseases (Dengue, Zika, Influenza, COVID-19)
• Clinical pharmacology & pharmacogenetics programme
• Chronobiology sleep and circadian rhythm studies

Collaboration with Duke University
SingHealth IMU, Duke University's Clinical Research Unit (Carolina, USA) and Medanta IMU (India) have signed a memorandum of understanding to facilitate appropriate multi-site studies at the three institutions.

Project that has been initiated since its launch include:

• Microarray signatures to aspirin response study
• Olfactory Bulb Imaging using MRI machine

Collaboration with Industry
SingHealth IMU has collaborative agreements with most major pharmaceutical companies and CROs, including:

• Covance

• Parexel

• IQVIA

• MSD

• GlaxoSmithKline (GSK)

• Novartis OTM

• PPD

• Servier

• Arcturus Therapeutics

• Pfizer

• Esai

• Takeda/Millennium

• Bayer

• Boehringer Ingelheim

• Sanofi

• Fibrogen

• AstraZeneca

Site Inspections & Audits
SingHealth IMU has been inspected by the Health Sciences Authority of Singapore and audited by major pharmaceutical companies / CROs such as GSK, IQVIA, Celerion and is approved as a full clinical trial site.